Pharmaceutical Supplier – Lidocaine Hydrochloride and Epinephrine Injection

The contract involves the supply of Lidocaine Hydrochloride and Epinephrine Injection in predetermined packaging units, requiring full compliance with FDA regulations, United States Pharmacopeia standards, and military-specific packaging requirements. The product must be manufactured and packaged to meet the strict quality and safety benchmarks set by these authorities to ensure suitability for use in military and defense medical applications. All deliveries are to be fulfilled to the specified place of performance, identified as FPO with ZIP code 96691, indicating delivery to a U.S. military postal address. Subcontractors responding to this solicitation must submit proposals by the deadline of August 5, 2026, following the NAICS code 325412 for pharmaceutical preparation manufacturing. The agency managing the requirement is the Department of Defense, specifically under the Medical Supply Chain Pharm FSA, which oversees the procurement of critical medical pharmaceuticals for military use. The contract is classified as a subcontract and is posted on the DIBBS system, where interested parties can access the official solicitation details through the provided link. There is no set-aside designation, meaning all eligible vendors may compete without restriction based on business size or socioeconomic status.